Barbara Yanni - May 10, 2024 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role: Director
Signature: /s/ Maurice Zauderer, Attorney-in-Fact for Barbara Yanni
Stock symbol: VCNX
Transactions as of: May 10, 2024
Transactions value $: $0
Form type: 4
Date filed: 5/14/2024, 04:33 PM
Previous filing: Jun 20, 2023
Next filing: Jun 14, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCNX	Stock Option (Right to Buy)	Award	$0	+10.1K	$0.00	10.1K	May 10, 2024	Common Stock	10.1K	$5.75	Direct	F7
holding	VCNX	Stock Option (Right to Buy)					30	May 10, 2024	Common Stock	30	$2,856.00	Direct	F1
holding	VCNX	Stock Option (Right to Buy)					36	May 10, 2024	Common Stock	36	$1,633.80	Direct	F2
holding	VCNX	Stock Option (Right to Buy)					74	May 10, 2024	Common Stock	74	$829.50	Direct	F3
holding	VCNX	Stock Option (Right to Buy)					136	May 10, 2024	Common Stock	136	$451.50	Direct	F4
holding	VCNX	Stock Option (Right to Buy)					253	May 10, 2024	Common Stock	253	$235.20	Direct	F5
holding	VCNX	Stock Option (Right to Buy)					684	May 10, 2024	Common Stock	684	$86.10	Direct	F6

Showing 1 to 7 of 7 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Exercisable in full as of the date of this report.
F2	This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F3	This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F4	This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F5	This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F6	This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F7	This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 10, 2034 or five years following retirement or cessation of services, whichever occurs first.

Remarks:

All figures in this Form 4 reflect the Issuer's 1-for-15 reverse stock split effected on September 25, 2023 and 1-for-14 reverse stock split effected on February 19, 2024.